You are here

InnoCan Pharma Corporation

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
INNO
CSE Index: 
Currency: 

The Corporation's business can be described as three distinct operating segments relating to the incorporation in products of CBD in their formulation: (i) research, development, marketing, distribution and sales of InnoCan-branded OTC pharmaceutical products; (ii) research and development of non-pharmaceutical products for third parties in exchange for fees and/or royalties; and (iii) research and development of hydrogels containing liposomes intended for licensing or sale to third party pharmaceutical corporations for manufacturing, distribution and sales.

You are here

InnoCan Pharma Corporation (INNO)

SEDAR Information

Company Info

Address
10 Hamenofim Street
Herzliya 4672561
Israel
Phone
972-54-301-2842
Email
irisb@innocanpharma.com
Website
http://innocanpharma.com
Listing date
Tuesday, September 24, 2019
Transfer Agent
Odyssey Trust Company

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
143,866,169
Reserved for Issuance: 
22,666,583

News Releases

05/11/2019

Press Release

21/10/2019

Press Release

Bulletins

24/09/2019

2019-0927 – New Listing - InnoCan Pharma Corporation (INNO)

le 24 septembre/September 2019

The common shares of InnoCan Pharma Corporation have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

Advertisement

Publicité

Latest CSE News

Upcoming Events

11_12_Northwind_Forum_Website

Northwind’s 13th Annual Capital Markets Invitational Forum

Tuesday, November 12, 2019 (All day) to Wednesday, November 13, 2019 (All day)
11_12_2nd_Annual_Boston_Cannabis_Conference_Website

2nd Annual Boston Cannabis Conference

Tuesday, November 12, 2019 (All day) to Wednesday, November 13, 2019 (All day)